Epithelial intrinsic inflammasomes direct host defense against gut microbes
上皮内在炎症小体直接引导宿主防御肠道微生物
基本信息
- 批准号:10428520
- 负责人:
- 金额:$ 8.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteCASP1 geneCaspaseCell DeathCellsChildChronicDendritic CellsDevelopmentDiarrheaDiseaseEnterocytesEpithelialEpithelial CellsEventExhibitsFamilyGastrointestinal tract structureGlycoproteinsGoblet CellsGut MucosaHomeostasisHost DefenseImmuneImmune responseIn VitroInfectionInflammasomeInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInnate Immune ResponseInterferon Type IIInterleukin-1 betaInterleukin-18InterventionIntestinal MucosaIntestinesInvadedKnowledgeLamina PropriaLeadLectinLyticMediatingMediator of activation proteinMicrobeModelingMorbidity - disease rateMucinsMucous MembraneMucous body substanceMultiprotein ComplexesNauseaPainPathway interactionsRegulationResearchRoleSalmonella typhimuriumSignal TransductionStimulusSurfaceTestingTherapeuticViralantimicrobialcytokinedefense responsedefined contributionenteric infectionenteric pathogenfight againstgastrointestinal epitheliumgastrointestinal infectiongut microbesin vivointestinal epitheliumknock-downmacrophagemicrobialmicrobial hostmonolayermortalityneutrophilpathogenpreventrational designrecruitresistinresponsesensor
项目摘要
PROJECT SUMMARY
Enteric infections and their associated sequelae, including pain, nausea, inflammation and diarrhea, are major
causes of morbidity and mortality worldwide, particularly in children. Being at the frontline of intestinal host
defense, intestinal epithelial cells (IECs) are the frequent target of enteric pathogens. It is generally believed
that during enteric infections, the gut epithelium and overlying mucus layer, which are at the forefront of the
host-microbial interface, primarily provide a physical barrier against invading pathogens, whereas any innate
immune response that occurs within the intestinal mucosa is largely driven by the immune/inflammatory cells
resident in the lamina propria. In contrast, recent studies, including our own, ascribe an unprecedented role for
IECs as important players in gut innate immune responses. Together, these studies unequivocally showed that
canonical and non-canonical inflammasomes in IECs promote host defense and inflammatory responses at
early stages of infection by the model enteric pathogen, Salmonella enterica serovar Typhimurium. The
primary objective of this application is to define the contribution of IEC inflammasomes to antimicrobial host
defenses in the gut. Our general hypothesis is that IEC intrinsic inflammasomes coordinate several protective
and anti-microbial pathways at the gut mucosal surface. Two integrated specific aims are proposed to test this
hypothesis. First, we will delineate the protective role of IEC inflammasomes against enteric pathogens in vitro
and in vivo, and assess the regulation and temporal contribution of IEC canonical and non-canonical
inflammasomes during infection. Second, we will elucidate goblet cell-specific inflammasome-dependent
defense responses. Completion of this proposal will close a significant knowledge gap regarding the impact of
epithelium-intrinsic inflammasomes on intestinal antimicrobial defense, homeostasis and disease development.
项目概要
肠道感染及其相关后遗症,包括疼痛、恶心、炎症和腹泻,是主要的
全世界尤其是儿童发病和死亡的原因。站在肠道宿主的最前线
肠道上皮细胞(IEC)是肠道病原体的常见目标。人们普遍认为
在肠道感染期间,肠道上皮和上面的粘液层位于肠道的最前部。
宿主-微生物界面,主要提供针对入侵病原体的物理屏障,而任何先天的
肠粘膜内发生的免疫反应很大程度上是由免疫/炎症细胞驱动的
居住于固有层。相比之下,最近的研究,包括我们自己的研究,都赋予了前所未有的作用
IEC 作为肠道先天免疫反应的重要参与者。总之,这些研究明确表明
IEC 中的典型和非典型炎症小体促进宿主防御和炎症反应
模型肠道病原体、鼠伤寒沙门氏菌感染的早期阶段。这
本申请的主要目的是确定 IEC 炎症小体对抗菌宿主的贡献
肠道内的防御。我们的一般假设是 IEC 内在炎症小体协调多种保护作用
以及肠道粘膜表面的抗菌途径。提出了两个综合的具体目标来测试这一点
假设。首先,我们将在体外描述 IEC 炎症小体对肠道病原体的保护作用
和体内,并评估 IEC 规范和非规范的调节和时间贡献
感染期间的炎症小体。其次,我们将阐明杯状细胞特异性炎症小体依赖性
防御反应。该提案的完成将弥补关于影响的重大知识差距
上皮固有炎症小体对肠道抗菌防御、稳态和疾病发展的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leigh Knodler其他文献
Leigh Knodler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leigh Knodler', 18)}}的其他基金
A bacterial biosensor for intracellular metal availability in the gut
用于肠道内细胞内金属可用性的细菌生物传感器
- 批准号:
10353307 - 财政年份:2022
- 资助金额:
$ 8.34万 - 项目类别:
A bacterial biosensor for intracellular metal availability in the gut
用于肠道内细胞内金属可用性的细菌生物传感器
- 批准号:
10763683 - 财政年份:2022
- 资助金额:
$ 8.34万 - 项目类别:
A bacterial biosensor for intracellular metal availability in the gut
用于肠道内细胞内金属可用性的细菌生物传感器
- 批准号:
10764453 - 财政年份:2022
- 资助金额:
$ 8.34万 - 项目类别:
Epithelial intrinsic inflammasomes direct host defense against gut microbes
上皮内在炎症小体直接引导宿主防御肠道微生物
- 批准号:
10202411 - 财政年份:2018
- 资助金额:
$ 8.34万 - 项目类别:
Epithelial intrinsic inflammasomes direct host defense against gut microbes
上皮内在炎症小体直接引导宿主防御肠道微生物
- 批准号:
10801424 - 财政年份:2018
- 资助金额:
$ 8.34万 - 项目类别:
相似国自然基金
辣椒茎秆匍匐基因CaSP1的克隆与功能解析
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
ß-hydroxybutyrate inhibition of pathology in Alzheimer's disease
α-羟基丁酸对阿尔茨海默病病理学的抑制作用
- 批准号:
10739679 - 财政年份:2023
- 资助金额:
$ 8.34万 - 项目类别:
Pentagalloyl glucose as an inhibitor of monosodium urate induced inflammation
五没食子酰葡萄糖作为尿酸钠诱导炎症的抑制剂
- 批准号:
10535379 - 财政年份:2023
- 资助金额:
$ 8.34万 - 项目类别:
Shigella mediated regulation of epithelial cell inflammasomes
志贺氏菌介导的上皮细胞炎症小体的调节
- 批准号:
10608342 - 财政年份:2023
- 资助金额:
$ 8.34万 - 项目类别:
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
- 批准号:
10571353 - 财政年份:2023
- 资助金额:
$ 8.34万 - 项目类别: